IV Conivaptan Helps Correct Sodium/Water Imbalance
The FDA has approved conivaptan HCl injection (YM087, Vaprisol, Astellas Pharma), an arginine vasopressin (AVP) antagonist for hospitalized patients with euvolemic hyponatremia. Euvolemic hyponatremia is a potentially life-threatening condition that occurs when the body’s blood sodium level falls significantly below normal. Hyponatremia affects almost 4% of hospitalized patients in the U.S. each year. Although many [...]
Read User's Comments